Global Autologous Cell Therapy Market Size, Share, Growth Analysis Report - Forecast 2034
Autologous Cell Therapy Market By Therapy Type (Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies), By Source (Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem Cells, Chondrocytes, Others), Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Others), End User (Hospitals & Clinics, Ambulatory Centers, Academics & Research, Others), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 255 Report Code: ZMR-6178
Published Date: Jun-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 5.68 Billion | USD 40.88 Billion | 21.82% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Autologous Cell Therapy Market, (2022 - 2028) (USD Million)
- 2.2 Global Autologous Cell Therapy Market : snapshot
- Chapter 3. Global Autologous Cell Therapy Market - Industry Analysis
- 3.1 Autologous Cell Therapy Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 The increasing prevalence of chronic diseases aids the global market growth
- 3.3 Market Restraints
- 3.3.1. The high cost of therapy may hamper the global market growth
- 3.4 Market Opportunities
- 3.4.1. The strategic initiatives by companies bring up several growth opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Source
- 3.7.2 Market attractiveness analysis By Application
- 3.7.3 Market attractiveness analysis By End-user
- Chapter 4. Global Autologous Cell Therapy Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Autologous Cell Therapy Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Autologous Cell Therapy Market - Source Analysis
- 5.1 Global Autologous Cell Therapy Market overview: By Source
- 5.1.1 Global Autologous Cell Therapy Market share, By Source, 2021 and 2028
- 5.2 Bone Marrow
- 5.2.1 Global Autologous Cell Therapy Market by Bone Marrow, 2022 - 2028 (USD Million)
- 5.3 Epidermis
- 5.3.1 Global Autologous Cell Therapy Market by Epidermis, 2022 - 2028 (USD Million)
- 5.4 Mesenchymal Stem Cells
- 5.4.1 Global Autologous Cell Therapy Market by Mesenchymal Stem Cells, 2022 - 2028 (USD Million)
- 5.5 Hematopoietic Stem Cells
- 5.5.1 Global Autologous Cell Therapy Market by Hematopoietic Stem Cells, 2022 - 2028 (USD Million)
- 5.6 Chondrocytes
- 5.6.1 Global Autologous Cell Therapy Market by Chondrocytes, 2022 - 2028 (USD Million)
- 5.1 Global Autologous Cell Therapy Market overview: By Source
- Chapter 6. Global Autologous Cell Therapy Market - Application Analysis
- 6.1 Global Autologous Cell Therapy Market overview: By Application
- 6.1.1 Global Autologous Cell Therapy Market share, By Application, 2021 and 2028
- 6.2 Cancer
- 6.2.1 Global Autologous Cell Therapy Market by Cancer, 2022 - 2028 (USD Million)
- 6.3 Neurodegenerative Diseases
- 6.3.1 Global Autologous Cell Therapy Market by Neurodegenerative Diseases, 2022 - 2028 (USD Million)
- 6.4 Wound Healing
- 6.4.1 Global Autologous Cell Therapy Market by Wound Healing, 2022 - 2028 (USD Million)
- 6.5 Orthopedic
- 6.5.1 Global Autologous Cell Therapy Market by Orthopedic, 2022 - 2028 (USD Million)
- 6.6 Cardiovascular Diseases
- 6.6.1 Global Autologous Cell Therapy Market by Cardiovascular Diseases, 2022 - 2028 (USD Million)
- 6.7 Autoimmune Diseases
- 6.7.1 Global Autologous Cell Therapy Market by Autoimmune Diseases, 2022 - 2028 (USD Million)
- 6.1 Global Autologous Cell Therapy Market overview: By Application
- Chapter 7. Global Autologous Cell Therapy Market - End-user Analysis
- 7.1 Global Autologous Cell Therapy Market overview: By End-user
- 7.1.1 Global Autologous Cell Therapy Market share, By End-user, 2021 and 2028
- 7.2 Hospitals
- 7.2.1 Global Autologous Cell Therapy Market by Hospitals, 2022 - 2028 (USD Million)
- 7.3 Clinics
- 7.3.1 Global Autologous Cell Therapy Market by Clinics, 2022 - 2028 (USD Million)
- 7.4 Others
- 7.4.1 Global Autologous Cell Therapy Market by Others, 2022 - 2028 (USD Million)
- 7.1 Global Autologous Cell Therapy Market overview: By End-user
- Chapter 8. Autologous Cell Therapy Market - Regional Analysis
- 8.1 Global Autologous Cell Therapy Market Regional Overview
- 8.2 Global Autologous Cell Therapy Market Share, by Region, 2021 & 2028 (USD Million)
- 8.3. North America
- 8.3.1 North America Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
- 8.3.1.1 North America Autologous Cell Therapy Market, by Country, 2022 - 2028 (USD Million)
- 8.3.1 North America Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
- 8.4 North America Autologous Cell Therapy Market, by Source, 2022 - 2028
- 8.4.1 North America Autologous Cell Therapy Market, by Source, 2022 - 2028 (USD Million)
- 8.5 North America Autologous Cell Therapy Market, by Application, 2022 - 2028
- 8.5.1 North America Autologous Cell Therapy Market, by Application, 2022 - 2028 (USD Million)
- 8.6 North America Autologous Cell Therapy Market, by End-user, 2022 - 2028
- 8.6.1 North America Autologous Cell Therapy Market, by End-user, 2022 - 2028 (USD Million)
- 8.4. Europe
- 8.4.2 Europe Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
- 8.4.2.1 Europe Autologous Cell Therapy Market, by Country, 2022 - 2028 (USD Million)
- 8.4.2 Europe Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
- 8.4 Europe Autologous Cell Therapy Market, by Source, 2022 - 2028
- 8.4.1 Europe Autologous Cell Therapy Market, by Source, 2022 - 2028 (USD Million)
- 8.5 Europe Autologous Cell Therapy Market, by Application, 2022 - 2028
- 8.5.1 Europe Autologous Cell Therapy Market, by Application, 2022 - 2028 (USD Million)
- 8.6 Europe Autologous Cell Therapy Market, by End-user, 2022 - 2028
- 8.6.1 Europe Autologous Cell Therapy Market, by End-user, 2022 - 2028 (USD Million)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
- 8.5.3.1 Asia Pacific Autologous Cell Therapy Market, by Country, 2022 - 2028 (USD Million)
- 8.5.3 Asia Pacific Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
- 8.4 Asia Pacific Autologous Cell Therapy Market, by Source, 2022 - 2028
- 8.4.1 Asia Pacific Autologous Cell Therapy Market, by Source, 2022 - 2028 (USD Million)
- 8.5 Asia Pacific Autologous Cell Therapy Market, by Application, 2022 - 2028
- 8.5.1 Asia Pacific Autologous Cell Therapy Market, by Application, 2022 - 2028 (USD Million)
- 8.6 Asia Pacific Autologous Cell Therapy Market, by End-user, 2022 - 2028
- 8.6.1 Asia Pacific Autologous Cell Therapy Market, by End-user, 2022 - 2028 (USD Million)
- 8.6. Latin America
- 8.6.4 Latin America Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
- 8.6.4.1 Latin America Autologous Cell Therapy Market, by Country, 2022 - 2028 (USD Million)
- 8.6.4 Latin America Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
- 8.4 Latin America Autologous Cell Therapy Market, by Source, 2022 - 2028
- 8.4.1 Latin America Autologous Cell Therapy Market, by Source, 2022 - 2028 (USD Million)
- 8.5 Latin America Autologous Cell Therapy Market, by Application, 2022 - 2028
- 8.5.1 Latin America Autologous Cell Therapy Market, by Application, 2022 - 2028 (USD Million)
- 8.6 Latin America Autologous Cell Therapy Market, by End-user, 2022 - 2028
- 8.6.1 Latin America Autologous Cell Therapy Market, by End-user, 2022 - 2028 (USD Million)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
- 8.7.5.1 The Middle-East and Africa Autologous Cell Therapy Market, by Country, 2022 - 2028 (USD Million)
- 8.7.5 The Middle-East and Africa Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
- 8.4 The Middle-East and Africa Autologous Cell Therapy Market, by Source, 2022 - 2028
- 8.4.1 The Middle-East and Africa Autologous Cell Therapy Market, by Source, 2022 - 2028 (USD Million)
- 8.5 The Middle-East and Africa Autologous Cell Therapy Market, by Application, 2022 - 2028
- 8.5.1 The Middle-East and Africa Autologous Cell Therapy Market, by Application, 2022 - 2028 (USD Million)
- 8.6 The Middle-East and Africa Autologous Cell Therapy Market, by End-user, 2022 - 2028
- 8.6.1 The Middle-East and Africa Autologous Cell Therapy Market, by End-user, 2022 - 2028 (USD Million)
- Chapter 9. Company Profiles
- 9.1 Bayer AG
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Daiichi Sankyo Co. Ltd.
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Takeda Pharmaceutical Co. Ltd.
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Teva Pharmaceutical Industries Ltd.
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Holostem Terapie Avanzate Srl
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Vericel Corp.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Osiris Therapeutics Inc.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Brainstorm Cell Therapeutics Inc.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Sumitomo Chemical Co. Ltd.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 FUJIFILM Holdings Corp.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.1 Bayer AG
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
- 4. Porter’s Five Forces Analysis
- 5. Global Autologous Cell Therapy Market attractiveness, By Source
- 6. Global Autologous Cell Therapy Market attractiveness, By Application
- 7. Global Autologous Cell Therapy Market attractiveness, By End-user
- 8. Global Autologous Cell Therapy Market share by Source, 2022 and 2028 (USD Million)
- 9. Global Autologous Cell Therapy Market by Bone Marrow, 2022 - 2028 (USD Million)
- 10. Global Autologous Cell Therapy Market by Epidermis, 2022 - 2028 (USD Million)
- 11. Global Autologous Cell Therapy Market by Mesenchymal Stem Cells, 2022 - 2028 (USD Million)
- 12. Global Autologous Cell Therapy Market by Hematopoietic Stem Cells, 2022 - 2028 (USD Million)
- 13. Global Autologous Cell Therapy Market by Chondrocytes, 2022 - 2028 (USD Million)
- 14. Global Autologous Cell Therapy Market share by Application, 2022 and 2028 (USD Million)
- 15. Global Autologous Cell Therapy Market by Cancer, 2022 - 2028 (USD Million)
- 16. Global Autologous Cell Therapy Market by Neurodegenerative Diseases, 2022 - 2028 (USD Million)
- 17. Global Autologous Cell Therapy Market by Wound Healing, 2022 - 2028 (USD Million)
- 18. Global Autologous Cell Therapy Market by Orthopedic, 2022 - 2028 (USD Million)
- 19. Global Autologous Cell Therapy Market by Cardiovascular Diseases, 2022 - 2028 (USD Million)
- 20. Global Autologous Cell Therapy Market by Autoimmune Diseases, 2022 - 2028 (USD Million)
- 21. Global Autologous Cell Therapy Market share by End-user, 2022 and 2028 (USD Million)
- 22. Global Autologous Cell Therapy Market by Hospitals, 2022 - 2028 (USD Million)
- 23. Global Autologous Cell Therapy Market by Clinics, 2022 - 2028 (USD Million)
- 24. Global Autologous Cell Therapy Market by Others, 2022 - 2028 (USD Million)
- 25. Global Autologous Cell Therapy Market share, by Region, 2022 and 2028
- 26. North America Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
- 27. Europe Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
- 28. Asia Pacific Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
- 29. Latin America Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
- 30. The Middle-East and Africa Autologous Cell Therapy Market, 2022 - 2028 (USD Million)
Table Of Tables
- 1. Global Autologous Cell Therapy Market: Snapshot
- 2. Drivers of the Autologous Cell Therapy Market: impact analysis
- 3. North America Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 4. North America Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 5. North America Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 6. U.S. Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 7. U.S. Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 8. U.S. Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 9. Canada Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 10. Canada Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 11. Canada Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 12. Europe Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 13. Europe Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 14. Europe Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 15. Germany Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 16. Germany Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 17. Germany Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 18. France Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 19. France Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 20. France Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 21. U.K. Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 22. U.K. Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 23. U.K. Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 24. Italy Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 25. Italy Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 26. Italy Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 27. Spain Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 28. Spain Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 29. Spain Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 30. Rest of Europe Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 31. Rest of Europe Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 32. Rest of Europe Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 33. Asia Pacific Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 34. Asia Pacific Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 35. Asia Pacific Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 36. China Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 37. China Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 38. China Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 39. Japan Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 40. Japan Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 41. Japan Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 42. India Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 43. India Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 44. India Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 45. South Korea Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 46. South Korea Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 47. South Korea Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 48. South-East Asia Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 49. South-East Asia Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 50. South-East Asia Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 51. Rest of Asia Pacific Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 52. Rest of Asia Pacific Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 53. Rest of Asia Pacific Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 54. Latin America Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 55. Latin America Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 56. Latin America Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 57. Brazil Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 58. Brazil Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 59. Brazil Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 60. Mexico Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 61. Mexico Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 62. Mexico Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 63. Rest of Latin America Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 64. Rest of Latin America Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 65. Rest of Latin America Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 66. The Middle-East and Africa Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 67. The Middle-East and Africa Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 68. The Middle-East and Africa Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 69. GCC Countries Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 70. GCC Countries Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 71. GCC Countries Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 72. South Africa Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 73. South Africa Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 74. South Africa Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
- 75. Rest of Middle-East Africa Autologous Cell Therapy Market revenue, By Source, 2022 - 2028 (USD Million)
- 76. Rest of Middle-East Africa Autologous Cell Therapy Market revenue, By Application, 2022 - 2028 (USD Million)
- 77. Rest of Middle-East Africa Autologous Cell Therapy Market revenue, By End-user, 2022 - 2028 (USD Million)
Methodology
FrequentlyAsked Questions
The global autologous cell therapy market is expected to grow due to advancements in regenerative medicine, personalized treatment approaches, and rising prevalence of chronic diseases.
According to a study, the global autologous cell therapy market size was worth around USD 5.68 Billion in 2024 and is expected to reach USD 40.88 Billion by 2034.
The global autologous cell therapy market is expected to grow at a CAGR of 21.82% during the forecast period.
North America is expected to dominate the autologous cell therapy market over the forecast period.
Leading players in the global autologous cell therapy market include Bluebird bio Inc., Novartis, Gilead Sciences Inc. (Kite), Bristol-Myers Squibb Company, Pharmicell Co., Ltd., Johnson & Johnson (Janssen Global Services, LLC), JW Therapeutics, Holostem S.r.l., Vertex Pharmaceuticals Inc., Autolus Therapeutics, among others.
The report explores crucial aspects of the autologous cell therapy market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed